A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

Phase 1b study to evaluate combination of zongertinib and zanidatamab in HER2-positive breast cancer patients Ingelheim, Germany– 12 January, 2026 – Boehringer Ingelheim today announced a strategic ...

A team of Australian researchers have developed a new targeted therapeutic approach that could improve treatment for ...

Researchers at University of California San Diego have identified a previously unrecognized treatment target for ...

NP-G2-044 (Prilukae), a novel oral fascin inhibitor, has earned orphan drug designation (ODD) from the FDA for the treatment ...

MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.

Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...

Targeted therapies are a type of medicine used to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted ...